Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Urticaria Article
This is a selection made from among articles on Drug Treatment Urticaria. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Alcohol Rehab: How Rehab Centers Help Addiction Recovery
By Steven G
Alcohol addiction is a serious disease. Not only can alcohol addiction tear a family apart and lead to financial ruin, it can also lead to the premature death of the alcoholic. Therefore, it is vital for person suffering from this disease to find help immediately. Without help, it is nearly impossible for a person with an alcohol addiction to recover and return to a normal, healthy life.
Choosing the Right Alcohol Rehab Center
An alcohol rehab center is the best source for a person looking for assistance with addiction recovery. Therefore, it is necessary to determine the type of rehab center best suited to the individual's needs.
There are two forms of help a person with an alcohol addiction can receive from a rehab center: inpatient and outpatient. With inpatient treatment, the patient remains on the premises of the alcohol rehab center. Outpatient treatment, on the other hand, permits the individual to continue with his or her regular life while still reporting to the rehab center for assistance and guidance. The majority of alcohol rehab centers offer both forms of treatment.
The Support of an Alcohol Rehab Center
Regardless of the type of program the person with an alcohol addiction follows, the basics of alcohol rehab remain the same. In all cases, the addiction and other difficulties the patient faces are kept confidential. In addition, the rehab center will also include five primary components: a medical evaluation, a psychological evaluation, therapy, detox, and extended care.
The Medical Evaluation
The medical evaluation conducted by the alcohol rehab center is meant to help the staff identify any physical problems the person with an alcohol addiction may have. Often, these physical problems are actually caused by the alcohol addiction. Problems with the liver, for example, may have developed as a result of the addiction. After medical problems have been identified, the staff of the rehab center can work toward making the patient physically healthy once more.
Improving the patient's physical health is an important component of addiction recovery. This is because it takes a holistic approach to get an addict back on the road toward recovery. This includes taking care of the patient's physical, mental, and emotional health. Without this three-pronged approach, the patient is more likely to fail in the process of addiction recovery.
The Psychological Evaluation
The psychological evaluation also provides the staff of the rehab center with volumes of important information about the patient. The psychological evaluation helps the team better understand the patient. In addition, the team of specialists can determine whether the person suffering from alcohol addiction is also struggling from certain psychological problems. For example, it is common for a person suffering from alcohol addiction to also suffer from depression. If this is the case, the program developed to assist the patient will also include a plan to address this issue.
Therapy
Generally, an alcohol rehab center will provide both group and individual therapy to its patients. The group therapy is designed to give the person with an alcohol addiction support from others who are experiencing the same difficulties. Being able to share in the struggles with those who can truly understand often makes the process easier for a patient to deal with.
Nonetheless, individual counseling is also critical to addiction recovery. Having the opportunity to work one-on-one with a counselor helps the patient work through his or her own individual conflicts. Through individual therapy, the patient can come to terms with his or her addiction and work through ways to resolve it by setting individual goals.
Detoxification
In addition the medical and physical evaluations, patients of alcohol rehab centers generally undergo a 24-hour medically supervised detoxification and withdrawal period. During this period, the patient is forced to go without alcohol. For many patients coping with alcohol addiction, this may be the longest time they have gone without alcohol in many years.
The detoxification period is difficult for the person suffering from alcohol addiction because it is accompanied by extreme withdrawal symptoms. These symptoms take their toll on the patient both physically and mentally. For this reason, an alcohol rehab center also provides close patient monitoring and assistance during this period.
Rehab Extended Care
Extended care, which is also sometimes referred to as aftercare, is vital to the success of addiction recovery. Through an extended care program, the patient continues to receive support and assistance from the alcohol rehab center after being released from the more intensive alcohol rehab program.
Extended care programs are designed to help monitor the patient's success in alcohol addiction recovery. To do this appropriately, the program staff watch over the patient to be sure he or she is utilizing the new skills gained during rehab. For instance, the extended care specialist may work with the patient to be sure he or she is staying away from specific crowds of people that encourage drinking. Or, the extended care specialist may check to be sure the patient is utilizing appropriate resistance skills. Without a strong extended care program, it is easy for the patient to fall back into the cycle of abuse.
The California Rehab Guide lists and reviews drug rehab and alcohol rehab facilities, lawyers and interventionist and has articles on alcohol addiction recovery and addiction treatment.
Article Source: http://EzineArticles.com/?expert=Steven_G
http://EzineArticles.com/?Alcohol-Rehab:-How-Rehab-Centers-Help-Addiction-Recovery&id=162541
Drug Treatment Urticaria Specific links
Drug Treatment Urticaria News
Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A
Baxter International Inc. today announced the approval of ADVATE [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with hemophilia A in China by the State Food and Drug Administration .
Read more...Press Release
Pfizer Inc.(NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX, TASE:PLX) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved ELELYSO™ (taliglucerase alfa) for injection, an enzyme replacement therapy (ERT) for the long-term treatment of adults with a confirmed diagnosis of type 1 Gaucher disease.
Read more...Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO™ (taliglucerase alfa) For The Treatment Of ...
NEW YORK & CARMIEL, Israel--(BUSINESS WIRE)--Pfizer Inc.(NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX, TASE:PLX) announced today that the United States (U.S.) Food and Drug Administration (FDA) approved ELELYSO™ (taliglucerase alfa) for injection, an enzyme replacement therapy (ERT) for the long-term treatment of adults with a confirmed diagnosis of type 1 Gaucher disease. ELELYSO ...
Read more...Bestellen Sie den kostenlosen Newsletter von 4investors:
Novartis International AG / Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly . Processed and transmitted by Thomson Reuters ONE.
Read more...Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients ...
Novartis International AG / Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible …
Read more...ISTA Pharmaceuticals Reports Positive, Topline Results From Its Phase 2 Clinical Trial of BEPOSONE(TM) Nasal Spray for ...
IRVINE, CA-- - ISTA Pharmaceuticals, Inc. announced today positive results from its Phase 2 randomized, placebo-controlled, parallel-group environmental clinical study of BEPOSONE™ nasal spray for the ...
Read more...Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM) Depot Formulation for the Maintenance ...
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole intramuscular depot formulation for the maintenance treatment of adults with schizophrenia.
Read more...Bristol-Myers Squibb to Present New Data on ORENCIA® (abatacept) at the European League Against Rheumatism (EULAR ...
Bristol-Myers Squibb Company today announced that the company will present 18 abstracts on ORENCIA® at the European League Against Rheumatism Annual European Congress of Rheumatology in Berlin, June 6-9.
Read more...Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO (taliglucerase alfa) For The Treatment Of Gaucher ...
Pfizer Inc.(NYSE:PFE) and Protalix BioTherapeutics, Inc. (NYSE-AMEX:PLX, TASE:PLX) announced today that the United States ...
Read more...AMAG Pharmaceuticals Announces First Quarter 2012 Financial Results
AMAG Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of Feraheme® Injection for intravenous use to treat iron deficiency anemia , today reported unaudited consolidated financial results for the first quarter ended March 31, 2012.
Read more...